z-logo
open-access-imgOpen Access
PD-1 inhibitor toripalimab with gemcitabine as a neoadjuvant therapy for muscle-invasive bladder urothelial carcinoma
Author(s) -
Huaqi Yin,
Yongkang Ma,
Bao Guan,
Z. Shiming,
HE Chaohong,
Yang Tiejun
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000028591
Subject(s) - medicine , gemcitabine , cystectomy , neoadjuvant therapy , bladder cancer , carcinoma , immunotherapy , oncology , urology , chemotherapy , cancer , breast cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here